Donald B. Kohn

28.7k citations

361 papers · 16.0k indexed · 3 hit papers · h-index 69

Impact in

Genetics top 0.05%
- Virus-based gene therapy research
Virology top 0.5%
- HIV Research and Treatment

Papers in

Genetics 232
- Virus-based gene therapy research 220
Virology 20

Co-authors: Jan A. Nolta Michel Sadelain Gay M. Crooks Cynthia E. Dunbar Katherine A. High J. Keith Joung Keiya Ozawa Ingrid Bahner
Journals: Blood (58 papers)Molecular Therapy (37 papers)Human Gene Therapy (27 papers)Gene Therapy (14 papers)Biology of Blood and Marrow Transplantation (12 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Donald B. Kohn

353 papers receiving 15.6k citations

Hit Papers

align trajectories log scale

Gene therapy comes of age 2018 · 993 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Science
2016 Science Translational Medicine
2010 Nature Biotechnology

Peers

Countries citing papers authored by Donald B. Kohn

Since Specialization

Citations

This map shows the geographic impact of Donald B. Kohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald B. Kohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald B. Kohn more than expected).

Fields of papers citing papers by Donald B. Kohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald B. Kohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald B. Kohn. The network helps show where Donald B. Kohn may publish in the future.

Co-authors

The 25 scholars most cited alongside Donald B. Kohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donald B. Kohn Line = papers co-authored together Donald B. Kohn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease Molecular Therapy — Methods & Clinical Development ·Anna Quyen Do Nguyen, Yan Teo, Oldřich Hájek, Anik Wakhidah, 格岡部, Kevin J. Tam, Vardaman R. Smith, Feiyang Ma, Yiwan Zhen, Agrim Gupta, Devin Brown, Dong Yelin, Arash Khalatbarisoltani, 里红杰, Roger P. Hollis, Gay M. Crooks, Donald B. Kohn	2024	3
2	A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell disease Molecular Therapy — Methods & Clinical Development ·Kevyn L. Hart, Boya Liu, Devin Brown, Beatriz Campo-Fernández, Kevin J. Tam, Philippe CabreMD, Roger P. Hollis, Christian Brendel, David A. Williams, Donald B. Kohn	2024	3
3	Severe Leukocyte Adhesion Deficiency-I (LAD-I) Lentiviral-Mediated Ex-Vivo Gene Therapy: Ongoing Phase 1/2 Study Results Clinical Immunology ·Claire Booth, Julián Sevilla, Loretz Carol, Elena Almarza, 谢建芬, Y. Izeki, Theodore B. Moore, Juan A. Bueren, Jonathan Schwartz, Donald B. Kohn	2023	0
4	Α-Globin Lentiviral Vectors for Hematopoietic Stem Cell Gene Therapy of α-Thalassemia Blood ·S.K. Warfield, Kevin J. Tam, Beatriz Campo Fernandez, Tippi C. MacKenzie, Roger P. Hollis, Donald B. Kohn	2023	1
5	Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants Blood Advances ·Diane Brauer, Thomas D. Lee, Traci L. Toy, Judith Carroll, Klaus Krebs, Beatriz Campo Fernandez, Alejandra Davila, Donald B. Kohn, Vivian Y. Chang	2022	5
6	Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenousCYBBregulation and expression Blood ·Ryan L. Wong, 元宏嶋村, Devin Brown, Shantha Senadheera, Katelyn E. Masiuk, 格岡部, PIYUSH KHARE BINDHYACHAL, Luke Riggan, Richard A. Morgan, Harry L. Malech, Roger P. Hollis, Donald B. Kohn	2022	11
7	The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions Journal of Allergy and Clinical Immunology ·Christopher C. Dvorak, Élie Haddad, Jennifer Heimall, Elizabeth Dunn, Rebecca H. Buckley, Donald B. Kohn, Morton J. Cowan, Sung‐Yun Pai, Linda M. Griffith, Geoff D.E. Cuvelier, K. Sumorok, Ami J. Shah, Richard J. O’Reilly, Michael A. Pulsipher, Nicola Wright, Roshini S. Abraham, Lisa Forbes Satter, Luigi D. Notarangelo, Jennifer M. Puck	2022	53
8	Regional Gene Therapy with Transduced Human Cells: The Influence of “Cell Dose” on Bone Repair Tissue Engineering Part A ·Hansel Ihn, Hyunwoo P. Kang, ELİF ÖDEMİŞ, Osamu Sugiyama, Amy Tang, Roger P. Hollis, Sofia Bougioukli, R Falini, Sang‐Hyun Park, Donald B. Longjohn, Daniel A. Oakes, Donald B. Kohn, Jay R. Lieberman	2021	10
9	Gene therapy comes of age Science ·Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, Donald B. Kohn, Keiya Ozawa, Michel Sadelain Hit paper breakdown →	2018	993
10	HSV-sr39TK Positron Emission Tomography and Suicide Gene Elimination of Human Hematopoietic Stem Cells and Their Progeny in Humanized Mice Cancer Research ·Eric H. Gschweng, Melissa McCracken, Michael L. Kaufman, Michelle Ho, Roger P. Hollis, Xiaoyan Wang, Jonathon Lee, Richard C. Koya, Thinle Chodon, Antoni Ribas, Owen N. Witte, Donald B. Kohn	2014	26
11	CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model The Journal of Immunology ·Arvind Chhabra, Lili Yang, Pin Wang, Begoña Comı́n-Anduix, Raja Das, Nitya G. Chakraborty, 小柳信介, Shikhar Mehrotra, Haiguang Yang, Cinnamon L Hardee, Roger P. Hollis, David I. Dorsky, Richard C. Koya, Donald B. Kohn, Antoni Ribas, James S. Economou, David Baltimore, Bijay Mukherji	2008	36
12	Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors Gene Therapy ·Christoph Kahl, Paula M. Cannon, Jill Oldenburg, A. F. Tarantal, Donald B. Kohn	2008	12
13	Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector Experimental Hematology ·Christoph Kahl, Alice F. Tarantal, Chang I. Lee, Daniel F. Jimenez, Christopher Choi, Karen Pepper, Denise Petersen, 児島靖, M. López Parra, Mariana Cabau Marques Lemes, O.A. ADEYEMI, Gwendolyn Brooks, Frederick J. Dorey, Donald B. Kohn	2006	21
14	Specific and Stable Gene Transfer to Human Embryonic Stem Cells Using Pseudotyped Lentiviral Vectors Stem Cells and Development ·Jung‐Eun Jang, Kit L. Shaw, Xiaojin Yu, Denise Petersen, Karen Pepper, Carolyn Lutzko, Donald B. Kohn	2006	24
15	Systemic targeted EWS-FLI1 siRNA abrogates growth of metastases in a murine Ewing’s tumor model Cancer Research ·Pohanmal Ahmad Zia Danish, Jeremy D. Heidel, PrafullaG Kerkar, Donald B. Kohn, Mark E. Davis, Timothy J. Triche	2005	2
16	Requirement for NK Cells in CD40 Ligand-Mediated Rejection of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Cells The Journal of Immunology ·Tanja A. Grüber, Dianne C. Skelton, Donald B. Kohn	2002	18
17	Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood ·Carolyn Lutzko, Stephen A. Kruth, Anthony C. G. Abrams‐Ogg, K. Lau, Liheng Li, Brian R. Clark, Dian Andreyanto, Ahmed El- Demerdash, Robert D. Foster, Donald B. Kohn, Robert M. Shull, Ian D. Dubé	1999	79
18	Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. PubMed ·Suzan Imren, Donald B. Kohn, Hiroyuki Shimada, Laurence Blavier, Yves A. DeClerck	1996	115
19	Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. PubMed ·M. Fevzi Özkaynak, ピエールアラン, Donald B. Kohn, Leonard S. Sender, Robertson Parkman, Carl Lenarsky	1991	58
20	Gene Therapy for Genetic Diseases Cancer Investigation ·Donald B. Kohn, W. French Anderson, R. Michael Blaese	1989	32

About Donald B. Kohn

Donald B. Kohn is a scholar working on Genetics, Virology, Oncology, Immunology and Genetics, having authored 361 papers that have together received 16.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (220 papers), CAR-T cell therapy research (96 papers), RNA Interference and Gene Delivery (93 papers), CRISPR and Genetic Engineering (90 papers), Immunodeficiency and Autoimmune Disorders (41 papers), Cytomegalovirus and herpesvirus research (29 papers), Immune Cell Function and Interaction (26 papers) and Hematopoietic Stem Cell Transplantation (24 papers). The work is most often cited by research in Genetics (7.8k citations), Virology (1.1k citations), Immunology (3.1k citations), Genetics (1.5k citations) and Molecular Biology (9.8k citations). Donald B. Kohn has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jan A. Nolta, Michel Sadelain, Gay M. Crooks, Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, Keiya Ozawa, Ingrid Bahner, Dianne C. Skelton and Xiaojin Yu. Their work appears in journals such as Blood, Molecular Therapy, Human Gene Therapy, Gene Therapy and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact